Sotrovimab
Found 4 free book(s)A Detailed Guide for the Use of Sotrovimab
infusioncenter.orgSotrovimab is a human immunoglobulin G-1 (IgG1-kappa) monoclonal antibody that binds to a conserved epitope on the spike protein receptor binding domain of SARS-CoV-2. Sotrovimab does not compete with human ACE2 receptor binding. Sotrovimab requires 1 single-dose vial, 1 infusion bag, 30 minutes of infusion time, and
PI: XEVUDY (Sotrovimab) Concentrated injection solution ...
www.tga.gov.auSotrovimab is an engineered human IgG1 mAb that binds to a highly conserved epitope on the spike protein receptor binding domainof SARS-CoV …
Therapeutic Management of Hospitalized Adults With COVID ...
www.albertahealthservices.caSotrovimab. b. 500mg single dose IV. ANTICOAGULATION: In moderately sick hospitalized COVID-19 patients (requiring oxygen up to 15 L/min via nasal cannula) with no contraindications to anticoagulation and low
COVID-19 Outpatient Therapeutics
www.phe.govClinical Decision Aid for Pediatric Patients. Outpatient . 3.5 kg to less than 40 kg. or . younger than 12 years of age weighing at least 3.5 kg, with mild to moderate COVID -19 and at high risk